tiprankstipranks
Trending News
More News >
Interface (TILE)
NASDAQ:TILE

Interface (TILE) AI Stock Analysis

Compare
212 Followers

Top Page

TILE

Interface

(NASDAQ:TILE)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 5.2)
Rating:74Outperform
Price Target:
$35.00
▲(20.69% Upside)
Action:ReiteratedDate:02/24/26
The score is driven primarily by solid financial performance (improving profitability, stronger leverage profile, and healthy free cash flow) and a positive earnings outlook with supportive guidance and backlog trends. Valuation is reasonable, while technicals are the main offset due to weaker near-term momentum.
Positive Factors
Improved leverage & balance sheet
Interface materially lowered leverage (debt-to-equity ~0.63) and extended maturities, reducing refinancing risk and interest pressure. A stronger capital structure increases strategic optionality for capex, M&A, and shareholder returns while supporting durable operations.
Healthy cash generation
Sustained operating cash flow and a material free cash flow run-rate support reinvestment in automation and new products, debt paydowns, and rising dividends/share buybacks. Reliable cash conversion underpins long-term financial flexibility and capital allocation choices.
Product innovation & automation
The Noravant product platform and ongoing automation investments create structural upside: new addressable resilient categories and efficiency gains that expanded margins in 2025. Multi-year product ramps plus productivity programs can sustainably improve mix and operating leverage.
Negative Factors
Tariff volatility
Ongoing tariff and policy uncertainty creates a recurring margin risk that is hard to fully hedge. Unexpected tariff actions can compress gross margins and force pricing or sourcing changes, making medium-term margin forecasting and competitive positioning more volatile.
One-time margin benefit
A nonrecurring inventory reserve artificially boosted 2025 margins, reducing comparability to ongoing performance. This obscures the baseline margin run-rate and means part of recent expansion may reverse, complicating medium-term margin sustainability assessments.
Lengthy nora selling cycles
Longer selling cycles for nora and Noravant delay revenue realization and extend payback on commercialization costs. Gradual multi-quarter ramps increase execution risk, slow cash conversion from new products, and make growth timing and forecasting less predictable.

Interface (TILE) vs. SPDR S&P 500 ETF (SPY)

Interface Business Overview & Revenue Model

Company DescriptionInterface, Inc., a modular flooring company, designs, produces, and sells modular carpet products primarily in the Americas, Europe, and the Asia-Pacific. The company offers modular carpets under the Interface and FLOR brand names; carpet tiles under the GlasBacRE name for use in commercial interiors, including offices, healthcare facilities, airports, educational and other institutions, hospitality spaces, and retail facilities, as well as residential interiors; modular resilient flooring products; rubber flooring under the norament and noraplan brand names; and luxury vinyl tile products. It also produces and sells an adapted version of its carpet tile for the healthcare facilities market; and two-meter roll goods that are structure-backed for use in education, healthcare, and government markets, as well as carpet replacement, installation, and maintenance services. In addition, the company sells and licenses a proprietary antimicrobial chemical compound under the Intersept name for use in interior finishes; sells TacTiles, a carpet tile installation system, as well as various adhesives and products; and provides turnkey project management services for global accounts and other customers through its InterfaceSERVICES business. It sells its products directly to end-users, as well as indirectly through independent contractors or distributors, and FLOR line of products through Internet sales and commercial sales force. The company has product showrooms or design studios in the United States, Canada, Mexico, England, France, Germany, Spain, the Netherlands, India, Australia, Norway, the United Arab Emirates, Russia, Singapore, Hong Kong, Thailand, China, and others. Interface, Inc. was incorporated in 1973 and is headquartered in Atlanta, Georgia.
How the Company Makes MoneyInterface generates revenue primarily through the sale of its modular carpet tiles and flooring products to commercial customers and retailers. The company operates through direct sales and distribution channels, often leveraging partnerships with design firms and contractors to reach end-users. Key revenue streams include the sale of flooring products, installation services, and maintenance solutions. Additionally, Interface benefits from its emphasis on sustainability, attracting environmentally conscious clients and fulfilling corporate sustainability goals. The company has also formed significant partnerships with organizations promoting green building practices, which further enhances its market position and revenue opportunities.

Interface Earnings Call Summary

Earnings Call Date:Feb 24, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 01, 2026
Earnings Call Sentiment Positive
The call conveyed a broadly positive tone: management reported a record 2025 with strong top‑line growth, substantial margin expansion, meaningful segment outperformance (health care, education, nora rubber), healthy cash generation, disciplined capital allocation, and constructive 2026 guidance. The company also highlighted strategic progress—automation, the One Interface selling model, and a major new product (Noravant) with multiyear upside. Headwinds cited (tariff volatility, nonrecurring inventory/tax benefits, higher input costs, regional/order softness in some markets, and longer nora selling cycles) are tangible but described as manageable through pricing, productivity, and disciplined spending. On balance the positives and sustainable operating gains outweigh the one‑time items and risks discussed.
Q4-2025 Updates
Positive Updates
Record Financial Performance
Full year 2025 net sales of $1,390,000,000 (up 5.4% reported; currency‑neutral net sales +4.3% YoY). Full year adjusted operating income of $173.8M (up 22.9% YoY), adjusted EBITDA $217.9M (up 15.3% YoY), and adjusted diluted EPS $1.94 (up 33% YoY). Company described 2025 as a record year for net sales, adjusted operating income, and adjusted EBITDA.
Margins Expanded Meaningfully
Full year adjusted gross profit margin expanded to 39.0% (up ~187 basis points YoY). Fourth quarter adjusted gross profit margin was 38.6% (up 169 basis points YoY). Management expects 2026 adjusted gross margin of ~38.5%–39%.
Strong Q4 and Full-Year Operational Results
Q4 net sales $349.4M (up 4.3% as reported; currency‑neutral +1.6%); Q4 adjusted operating income $38.2M (up 16.7% YoY), Q4 adjusted EBITDA $49.8M (up 8.2% YoY), and Q4 adjusted EPS $0.49 (up 44.1% YoY).
Commercial Execution & Segment Wins (Health Care & Education)
Full year global health care billings +21% YoY (double‑digit gains in Americas and EAAA). Education billings +8% YoY. Q4 health care +11.7% and education +11.6%, reflecting share gains and strong demand.
nora Rubber Business Momentum
Global nora rubber billings up 17% in 2025, cited as a standout example of success from the One Interface combined selling teams; Noravant launch expected to further expand resilient market opportunity.
Product Innovation — Noravant Timber Launch
Launched Noravant (PVC‑free rubber sheet with wood grain 'Noravant Timber') to address premium vinyl sheet category and health care/education applications. Management expects Noravant to begin contributing in 2026 (~$5M–$10M in year‑one ramp) and projects the platform could deliver ~$50M–$100M over five years.
Productivity & Automation Investments
Ongoing investments in automation and robotics (U.S. carpet tile and nora plants) produced productivity gains and margin expansion; plans to extend robotic solutions to Europe and Australia and further automate cutting/packaging to drive efficiencies.
Healthy Cash Flow and Capital Allocation
Operating cash flow $167.9M in 2025 vs $148.4M in 2024. Capital expenditures $46.2M in 2025 with planned ~$55M in 2026 for automation and Noravant capacity. Returned cash via $18.2M share repurchases (full year) and increased quarterly dividend from $0.02 to $0.03 per share.
Balance Sheet & Leverage Management
Redeemed $300M of senior notes (used new $170M term loan + cash), repaid ~$124M of debt in 2025, and amended/extended syndicated credit facility to 2030 to reduce interest expense and extend maturities.
Positive 2026 Outlook & Backlog
Entered 2026 with orders/backlog up ~7% YTD. 2026 guidance: net sales $1.42B–$1.46B, adjusted gross margin ~38.5%–39%, SG&A ~26.2%–26.4% of net sales, capex ~$55M. Q1 2026 guide: net sales $315M–$325M and adjusted gross margin ~38%.
Negative Updates
Tariff Headwinds and Policy Uncertainty
Tariffs created dilution to gross profit: ~20 basis points in 2025 and expected ~50 basis points headwind in 2026. Management highlighted ongoing tariff volatility (Supreme Court and policy shifts) as a moving target and risk to margins.
One‑Time Inventory Reserve Benefit Inflated Margins
2025 adjusted gross profit benefited from a nonrecurring inventory reserve adjustment (management cited ~50–80 basis points benefit and noted this item will not recur), reducing comparability and partially inflating margin improvements.
Higher Input Costs and Inflationary Pressure
Higher input costs partially offset pricing/mix benefits. Management assumes modest raw material inflation going forward and notes input costs as a key risk to margin performance.
SG&A Dollar Increase Despite Discipline
Adjusted SG&A dollars increased to $366.7M in 2025 from $346.7M (primarily FX translation, higher salary/fringe and higher variable compensation); while SG&A was flat as a percent of sales, absolute SG&A rose and contains inflationary pressure.
Orders/Regional Softness and Retail Choppiness
Fourth quarter consolidated currency‑neutral orders increased only 2% YoY; EAAA orders were flat in Q4 and management noted a softer macro environment in some international markets. Retail was soft in the quarter and slightly depressed corporate growth in the period.
Nonrecurring Tax Benefit to Q4 EPS
A $2.9M valuation allowance release reduced the Q4 adjusted effective tax rate and added ~$+$0.05 to Q4 and full‑year adjusted EPS; management noted this benefit is nonrecurring, which reduces comparability of EPS levels.
nora Selling Cycle and Ramp Timeline
nora products (including Noravant) have a longer selling cycle spanning several quarters; management expects Noravant to start contributing meaningfully in 2026 but emphasized a gradual multi‑quarter ramp, delaying near‑term impact.
Exposure to Macro & Competitive Environment
Management flagged ongoing macro uncertainty and a competitive industry environment that could pressure demand, pricing, or scheduling, and noted the need to offset negative surprises via pricing and productivity.
Company Guidance
Interface provided Q1 2026 guidance of net sales of $315–$325 million, adjusted gross profit margin of ~38% of sales, adjusted SG&A of ~$94 million, adjusted interest and other of ~$4 million, an adjusted effective tax rate of ~18%, and a fully diluted share count of ~59.1 million; full‑year 2026 guidance is net sales of $1.42–$1.46 billion, adjusted gross profit margin of 38.5%–39.0%, adjusted SG&A of ~26.2%–26.4% of sales, adjusted interest and other of ~$16 million, an adjusted effective tax rate of 25%–26%, and capital expenditures of ~ $55 million, with the company noting a 53‑week year that should add roughly $5–$10 million to sales and a YTD backlog up ~7%.

Interface Financial Statement Overview

Summary
Financials are solid overall: improved profitability and margins with higher TTM earnings, better leverage (debt-to-equity ~0.63) and strong ROE (~20.6%), and healthy free cash flow (~$122M). Offsetting factors are only moderate revenue growth, historically cyclical profitability, and somewhat uneven cash conversion versus net income.
Income Statement
78
Positive
Profitability and momentum have improved meaningfully versus earlier years. TTM (Trailing-Twelve-Months) revenue is up about 4.8% year over year, while margins have expanded (gross margin ~38.2%, operating margin ~11.3%, net margin ~8.3%), driving higher earnings (TTM net income ~$116M vs. ~$87M in 2024 and ~$45M in 2023). The main weakness is that growth is steady rather than strong, and the business has shown cyclicality historically (notably weak profitability in 2020).
Balance Sheet
76
Positive
Leverage has improved substantially over time, with debt-to-equity moving down from elevated levels in 2020–2022 to ~0.63 in TTM (Trailing-Twelve-Months), indicating a stronger capital structure. Returns are also solid (TTM return on equity ~20.6%). Key watch-outs are that total debt remains meaningful (~$265M TTM) and the balance sheet has seen large equity swings across periods (e.g., much lower equity in 2023–2024 vs. TTM), which can signal structural changes that investors should monitor.
Cash Flow
73
Positive
Cash generation is healthy, with TTM (Trailing-Twelve-Months) operating cash flow of ~$168M and free cash flow of ~$122M. Free cash flow has accelerated sharply versus the prior period (TTM growth ~360%), supporting flexibility for reinvestment or capital returns. However, cash conversion is not perfect: free cash flow is ~75% of net income and operating cash flow is below net income (about 65%), suggesting working-capital or timing effects that can create volatility.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.39B1.32B1.26B1.30B1.20B
Gross Profit537.38M482.95M441.07M437.73M432.73M
EBITDA198.39M181.43M141.71M118.18M155.45M
Net Income116.10M86.95M44.52M19.56M55.23M
Balance Sheet
Total Assets1.77B1.17B1.23B1.27B1.33B
Cash, Cash Equivalents and Short-Term Investments71.32M99.23M110.50M97.56M97.25M
Total Debt264.53M383.14M515.45M610.62M615.59M
Total Liabilities565.85M681.67M804.15M904.97M966.66M
Stockholders Equity1.21B489.15M425.95M361.54M363.40M
Cash Flow
Free Cash Flow121.71M114.64M115.93M24.62M58.62M
Operating Cash Flow167.91M148.43M142.03M43.06M86.69M
Investing Cash Flow-46.19M-30.37M-19.51M-18.44M-28.07M
Financing Cash Flow-159.29M-125.23M-111.56M-19.49M-60.86M

Interface Technical Analysis

Technical Analysis Sentiment
Negative
Last Price29.00
Price Trends
50DMA
31.02
Negative
100DMA
29.04
Negative
200DMA
26.47
Positive
Market Momentum
MACD
-0.39
Positive
RSI
29.44
Positive
STOCH
6.10
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TILE, the sentiment is Negative. The current price of 29 is below the 20-day moving average (MA) of 32.56, below the 50-day MA of 31.02, and above the 200-day MA of 26.47, indicating a neutral trend. The MACD of -0.39 indicates Positive momentum. The RSI at 29.44 is Positive, neither overbought nor oversold. The STOCH value of 6.10 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TILE.

Interface Risk Analysis

Interface disclosed 9 risk factors in its most recent earnings report. Interface reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Interface Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$1.68B14.4120.55%0.21%5.11%34.02%
65
Neutral
$1.45B18.088.11%2.39%1.78%-25.36%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
59
Neutral
$1.36B11.21-1.95%4.16%4.34%-141.36%
57
Neutral
$1.53B6.4727.51%1.84%-6.03%
54
Neutral
$145.28M-1.14-11.27%7.20%-12.09%-204.66%
53
Neutral
$1.25B53.136.19%1.77%-44.11%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TILE
Interface
29.00
10.72
58.60%
MLKN
MillerKnoll
20.00
0.16
0.83%
HOFT
Hooker Furniture
13.53
1.98
17.14%
LZB
La-Z-Boy Incorporated
35.78
-4.78
-11.80%
LEG
Leggett & Platt
11.23
2.81
33.36%
MBC
MasterBrand Inc
9.59
-4.20
-30.46%

Interface Corporate Events

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
Interface Posts Record 2025 Results, Strengthens Financial Position
Positive
Feb 24, 2026

Interface reported record fourth-quarter and full-year 2025 results on February 24, 2026, with net sales rising 4.3% in the quarter to $349 million and 5.4% for the year to $1.39 billion, and GAAP earnings per diluted share reaching $0.41 for the quarter and $1.96 for 2025. Profitability improved as gross margin expanded to 38.7% for the year, adjusted EPS grew 33% to $1.94, and strong cash generation enabled $128 million of debt repayment, extended maturities to 2030, higher dividends and $13 million of share repurchases, underscoring the momentum of its One Interface strategy and market share gains in key sectors.

Management highlighted broad-based growth across regions and product categories, with especially strong 2025 billings in healthcare and education and continued share gains in corporate office. Executives emphasized that operational discipline, favorable pricing and mix, manufacturing efficiencies and disciplined capital allocation have strengthened the balance sheet and reinforced the company’s positioning as a design and sustainability leader despite ongoing macroeconomic uncertainty.

The most recent analyst rating on (TILE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on Interface stock, see the TILE Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Interface Amends Syndicated Facility Agreement
Neutral
Dec 3, 2025

Interface, Inc. entered into a Third Amended and Restated Syndicated Facility Agreement on December 3, 2025, with its foreign subsidiaries as co-borrowers and domestic subsidiaries as guarantors, alongside Bank of America and other lenders. The agreement introduces changes such as amended interest rates, an extended maturity date to December 3, 2030, a new $170 million term loan facility, and a reduced revolving credit facility. Additionally, Interface redeemed its $300 million Senior Notes due 2028 using proceeds from the term loan and cash on hand, effectively terminating obligations under the previous Indenture.

The most recent analyst rating on (TILE) stock is a Buy with a $31.00 price target. To see the full list of analyst forecasts on Interface stock, see the TILE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 24, 2026